Diabetes

New continuous glucose monitor systems provide additional support and quality of life improvements for patients with diabetes.

States with a higher prevalence of Medicaid patients with type 2 diabetes were found to have lower use ratio of glucose-lowering agents with known cardiovascular benefits.

The American Heart Association issued a dietary guidance in 2021 suggesting that adults consume a variety of fruits and vegetables, choose whole grains instead of refined grains, eat healthy protein sources and lean cuts of meat, and substitute nonfat and low-fat dairy products for full-fat versions, among other measures.

However, findings do not preclude the possibility that mechanisms other than cardiac remodeling may be responsible for benefits of SGLT2 inhibition.

Approximately 10% of patients in trial experienced a heart attack, stroke, blocked arteries requiring treatment, or death from cardiovascular disease.

When diabetes is uncontrolled, higher percentages of hemoglobin become glycated, which causes elevated HbA1c and glucose levels to rise within the body.

Education, awareness, and more training may help more pharmacists and kidney patients consider home dialysis as an effective treatment option, said an expert on November 4 at ASN Kidney Week in Orlando, Florida.

Daniel Weiner, MD, MS, associate professor at Tufts University, discusses effective treatment approaches for diabetic kidney disease at ASN Kidney Week.

Researchers observed disparities in health outcomes between Black individuals and White individuals due to stroke, diabetes, and coronary heart disease.

ASCP 2022 session presenters review the evidence that tipped the scales against the use of aspirin for primary prevention in patients aged 60 years or older.

Answering questions, monitoring, medication therapy, lifestyle modifications help prevent type 2 diabetes.

SGLT-2 inhibitors, GLP-1 receptor agonists, and a non-steroidal mineralocorticoid receptor are all showing promise in the prevention and management of diabetic kidney disease.

A continuous glucose monitoring system may allow patients with type 1 diabetes to have longer periods in target glucose levels and decrease the risk of complications from hyperglycemia.

Investigators found that lifestyle changes such as a high-quality diet and regular exercise can lower the risk of type 2 diabetes in women with a history of gestational diabetes mellitus.

Tirzepatide received Fast Track designation from the FDA after showing superiority to placebo in treating obesity in clinical trials.

Study finds cardioprotective medications were used in approximately 11% more men than women with type 1 diabetes.

Aflibercept 8 mg demonstrated non-inferiority in vision gains in both the 12- and 16-week dosing regimens.

Through gamification and food-focused activities, pharmacists can incentivize patient engagement in these services, even if offered outside the pharmacy.

New research suggests patients with type 2 diabetes who have elevated glycated hemoglobin levels, even when on metformin, could benefit by adding glucose-lowering glargine.

Continuous glucose monitors eliminate the need for frequent fingerstick use and carrying blood glucose monitoring supplies.

The study also showed sustained reductions in hospitalizations over a 2-year period of FreeStyle Libre system use.

Semaglutide is a traditional type 2 diabetes treatment that may help obese individuals lose weight, especially if given at a higher dose.

Adults with type 2 diabetes may benefit from eating more whole grains, fish, fiber, and omega-3 fatty acids in their diet, which could lower co-morbidities associated with death.

New research suggests that 200 g/day of milk can reduce the risk of type 2 diabetes by 10%.

Care Coach program offers a comprehensive set of pharmacy and counseling services to patients struggling to manage their diabetes.

Researchers found that patients diagnosed with early-onset type 2 diabetes have a greater risk of premature death than the general population.

Research suggests that subcutaneous insulin aspart is a cost-effective and accessible treatment option that could allow children with type 1 diabetes to avoid the ICU after a mild episode of diabetic ketoacidosis.

The long-acting, once-daily hormone controls high blood sugar in individuals aged 1 year or older with diabetes.

Research suggests that non-traditional complications from type 2 diabetes are hospitalizing more people now than they did 20 years ago.

Dual GIP/GLP-1 agonist therapy demonstrated superior glucose control and weight loss in patients with diabetes compared to selective GLP-1 receptor agonists in preclinical and clinical trials.